Clinical evidence for both the CyberKnife and TomoTherapy Systems: access to 100 presentations/posters is on the ESTRO internet site. The brand new Delivery Analysis Software for the TomoTherapy System Delivery Analysis for the TomoTherapy System lately received 510 clearance from the U.S. Food and Drug Administration , in conjunction with the CE Tag in the European Union. The Delivery Analysis software is an innovative device that leverages the unique architecture of the TomoTherapy System to provide unprecedented access to treatment delivery details.A two-sided significance level of 0.05 was used for all analyses, and P values for variations in baseline characteristics were not adjusted for multiplicity. Results Patients The % change in hemoglobin level in response to the first two weight-based dosages of darbepoetin alfa was normally distributed. Patients in the lowest quartile of hemoglobin responsiveness to the initial weight-based two dosages of darbepoetin alfa had a median reduction in hemoglobin degree of 0.7 to 0.0) and were thought to have had an unhealthy initial response .